Translational data validate mechanism of first-in-concept extracellular-cleaving ADC micvotabart pelidotin (MICVO)MICVO combats solid tumors ...
An analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed continuing improvements in cognition ...
A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results